Terms: = Endocrine gland cancer AND WIF1, WIF-1, 11197, ENSG00000156076 AND Clinical Outcome
2 results:
1. Dysregulated miR-137 and its target EGFR contribute to the progression of pituitary adenomas.
Wei D; Yu Z; Cheng Y; Jiawei H; Jian G; Hua G; Guilan D
Mol Cell Endocrinol; 2021 Jan; 520():111083. PubMed ID: 33246030
[TBL] [Abstract] [Full Text] [Related]
2. m
Tang B; Yang Y; Kang M; Wang Y; Wang Y; Bi Y; He S; Shimamoto F
Mol Cancer; 2020 Jan; 19(1):3. PubMed ID: 31906946
[TBL] [Abstract] [Full Text] [Related]
